Literature DB >> 23186936

Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study.

Damien Logeart1, Richard Isnard, Matthieu Resche-Rigon, Marie-France Seronde, Pascal de Groote, Guillaume Jondeau, Michel Galinier, Geneviève Mulak, Erwan Donal, François Delahaye, Yves Juilliere, Thibaud Damy, Patrick Jourdain, Fabrice Bauer, Jean-Christophe Eicher, Yannick Neuder, Jean-Noël Trochu.   

Abstract

AIMS: To improve knowledge of epidemiological data, management, and clinical outcome of acute heart failure (AHF) in a real-life setting in France. METHODS AND
RESULTS: We conducted an observational survey constituting a single-day snapshot of all unplanned hospitalizations because of AHF in 170 hospitals throughout France (the OFICA survey). A total of 1658 patients (median age 79 years, 55% male) were included. Family doctors were the first medical contact in 43% of cases, and patients were admitted through emergency departments in 64% of cases. Clinical scenarios were mainly acutely decompensated HF (48%) and acute pulmonary oedema (38%) with similar clinical and biological characteristics as well as outcome. Characteristics were different and severity higher in both shock and right HF. Infection and arrhythmia were the most frequent precipitating factors (27% and 24% of cases); diabetes and chronic pulmonary disease were the most frequent co-morbidities (31% and 21%). Over 80% of patients underwent both natriuretic peptide testing and echocardiography. LVEF was preserved (>50%) in 36% of patients and associated with specific characteristics and lower severity. Median hospital stay was 13 days; in-hospital mortality was 8.2%, and independent predictors were age, blood pressure, and creatinine. Treatment at discharge in patients with reduced LVEF included ACE inhibitors/ARBs, beta-blockers, and aldosterone inhibitors in 78, 67, and 27% cases. Non-surgical devices were reported in <20% of potential candidates.
CONCLUSION: This comprehensive survey analysing AHF in real life emphasizes the heterogeneous nature and overall high severity of AHF. It could be a useful tool to identify unsolved medical issues and improve outcome. TRIAL REGISTRATION: NCT01080937.

Entities:  

Mesh:

Year:  2012        PMID: 23186936     DOI: 10.1093/eurjhf/hfs189

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  35 in total

1.  Morphine Use in the Treatment of Acute Cardiogenic Pulmonary Edema and Its Effects on Patient Outcome: A Systematic Review.

Authors:  Víctor Gil; Alberto Domínguez-Rodríguez; Josep Masip; W Frank Peacock; Òscar Miró
Journal:  Curr Heart Fail Rep       Date:  2019-08

2.  Pulmonary Oedema-Therapeutic Targets.

Authors:  Ovidiu Chioncel; Sean P Collins; Andrew P Ambrosy; Mihai Gheorghiade; Gerasimos Filippatos
Journal:  Card Fail Rev       Date:  2015-04

Review 3.  Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance.

Authors:  A Mebazaa; H Tolppanen; C Mueller; J Lassus; S DiSomma; G Baksyte; M Cecconi; D J Choi; A Cohen Solal; M Christ; J Masip; M Arrigo; S Nouira; D Ojji; F Peacock; M Richards; N Sato; K Sliwa; J Spinar; H Thiele; M B Yilmaz; J Januzzi
Journal:  Intensive Care Med       Date:  2015-09-14       Impact factor: 17.440

4.  Pulmonary Congestion by Lung Ultrasound in Ambulatory Patients With Heart Failure With Reduced or Preserved Ejection Fraction and Hypertension.

Authors:  Kristin H Dwyer; Allison A Merz; Eldrin F Lewis; Brian L Claggett; Daniela R Crousillat; Emily S Lau; Montane B Silverman; Julie Peck; Jose Rivero; Susan Cheng; Elke Platz
Journal:  J Card Fail       Date:  2018-03-01       Impact factor: 5.712

5.  Predictive risk factors for death in elderly patients after hospitalization for acute heart failure in an internal medicine unit.

Authors:  Camille Roubille; Benjamin Eduin; Cyril Breuker; Laetitia Zerkowski; Simon Letertre; Cédric Mercuzot; Jonathan Bigot; Guilhem Du Cailar; François Roubille; Pierre Fesler
Journal:  Intern Emerg Med       Date:  2022-04-22       Impact factor: 5.472

6.  Acute heart failure in the emergency department: a follow-up study.

Authors:  Andrea Fabbri; Giulio Marchesini; Giorgio Carbone; Roberto Cosentini; Annamaria Ferrari; Mauro Chiesa; Alessio Bertini; Federico Rea
Journal:  Intern Emerg Med       Date:  2015-10-27       Impact factor: 3.397

7.  Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction.

Authors:  Nicolas Girerd; Jean-Jacques Von Hunolstein; Pierpaolo Pellicori; Antoni Bayés-Genís; Tiny Jaarsma; Lars H Lund; Pascal Bilbault; Jean-Marc Boivin; Tahar Chouihed; Jérôme Costa; Jean-Christophe Eicher; Estelle Fall; David Kenizou; Bruno Maillier; Pierre Nazeyrollas; Gérald Roul; Noura Zannad; Patrick Rossignol; Marie-France Seronde
Journal:  ESC Heart Fail       Date:  2022-04-15

8.  Chronic Heart Failure Clinical Practice Guidelines' Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?

Authors:  Ramon F Abarquez; Paul Ferdinand M Reganit; Carmen N Chungunco; Jean Alcover; Felix Eduardo R Punzalan; Eugenio B Reyes; Elleen L Cunanan
Journal:  ASEAN Heart J       Date:  2016-03-08

9.  Management of suspected acute heart failure dyspnea in the emergency department: results from the French prospective multicenter DeFSSICA survey.

Authors:  Tahar Chouihed; Stéphane Manzo-Silberman; Nicolas Peschanski; Sandrine Charpentier; Meyer Elbaz; Dominique Savary; Eric Bonnefoy-Cudraz; Said Laribi; Patrick Henry; Nicolas Girerd; Faiez Zannad; Carlos El Khoury
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-09-17       Impact factor: 2.953

10.  Hospital and 4-Year Mortality Predictors in Patients With Acute Pulmonary Edema With and Without Coronary Artery Disease.

Authors:  Jaume Figueras; Jordi Bañeras; Carlos Peña-Gil; José A Barrabés; Jose Rodriguez Palomares; David Garcia Dorado
Journal:  J Am Heart Assoc       Date:  2016-02-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.